Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (Review)

Liver cancer is the sixth most prevalent type of cancer worldwide and accounts for the third most frequent cause of cancer-associated mortality. Conventional anticancer drugs display limited efficacy owing to their short half-life, poor solubility and inefficient drug delivery. Despite advancements...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa, Nikita, Chwae, Yong Joon, Yoo, Kwang Ho, Won, Tae-Bin, Kang, Daewook, Choi, Daae, Kim, Jaeyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728509/
https://www.ncbi.nlm.nih.gov/pubmed/36416311
http://dx.doi.org/10.3892/ijmm.2022.5206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728509/
https://www.ncbi.nlm.nih.gov/pubmed/36416311
http://dx.doi.org/10.3892/ijmm.2022.5206

Ejemplares similares